• New Transdermal Release Liner Helps Overcome Challenges with Difficult Formulations

    February 08, 2016

    webLoaded = "false"
    • ST. PAUL, MN – February 8, 2016 – As patient preference and compliance are becoming increasingly important, transdermal patches are a great alternative for those who struggle with swallowing pills or want a more comfortable alternative to injections. One of the critical considerations when creating a transdermal patch is selection of the appropriate components – and 3M Drug Delivery Systems is adding another option to help meet customer needs. Introducing 3M™ Scotchpak™ 9709 Release Liner – a fluorosilicone coated polyester film recommended for formulations that require resistance to interactions with amines in silicone adhesives. Such formulations include those containing: Buprenorphine, Fentanyl, Lidocaine, Methylphenidate, Rivastigmine, and Rotigotine.

      The release liner is coated on one side with a proprietary 3M fluorosilicone that provides premium release from most pressure sensitive adhesives, including silicone, acrylic and polyisobutylene (PIB). The transparent liner is also occlusive and provides excellent chemical stability with potential to extend shelf life.

      3M Scotchpak 9709 release liner offers the lowest release within the 3M Scotchpak™ family of polyester release liners. Available in roll form, 3M Scotchpak™ 9709 release liner can be used in the fabrication of transdermal drug delivery systems.

      For more information, call 1-800-643-8086 (US), 44-1509-613626 (UK) or visit http://go.3m.com/tddsample to order a sample.

      ###

      About 3M Drug Delivery Systems

      3M Drug Delivery Systems partners with pharmaceutical and biotech companies to develop and manufacture pharmaceutical products using 3M's inhalation, transdermal or microneedle drug delivery technology. 3M offers a full range of feasibility, development and manufacturing capabilities to help bring products to market. Regulatory expertise, quality assurance, operations, marketed product support and other in-house resources are available for each step of the development and commercialization process. For more information, please visit www.3M.com/dds or call 1-800-643-8086.

      About 3M

      At 3M, we apply science in collaborative ways to improve lives daily. With $30 billion in sales, our 90,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNewsroom. 3M and Scotchpak are trademarks of 3M Company.

      Contacts:

      Michael Gugala
      Karwoski & Courage
      (612) 342-9604
      m.gugala@creativepr.com

      3M Drug Delivery Systems
      3M Center, Bldg 275-3E-10
      St. Paul, MN 55144